Microbiota-Modulators to improve Glucose Metabolism & Human Health (Diabetes related conditions). Probiotics & Postbiotics & Synbiotics for improving glucose metabolic disorders (Prediabetes, Diabetes & Gestational Diabetes). Our goals: prevent, delay disease progression, reduce complications and risk of Diabetes. Our lead product is pA1c a probiotic strain selected for blood sugar regulation. Mechanism of action published. Own strain collection, Strong IP, Safety & Scientific evidence. Genbioma is focused on international market. B2B business model